IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.
about
IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearanceA variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusInterferon-λ: Immune Functions at Barrier Surfaces and BeyondRegulation of hepatic innate immunity by hepatitis C virusNatural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experienceImmune responses to HCV and other hepatitis virusesSTAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liverEmerging concepts in immunity to hepatitis C virus infection.Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactionsInnate immune responses in hepatitis C virus infectionThe Role of Interferon Lambda 3 Genetic Polymorphisms in Response to Interferon Therapy in Chronic Hepatitis B Patients: An Updated Meta-AnalysisInterferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burdenIdentification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortRelation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver diseaseSequence analysis of the IL28A/IL28B inverted gene duplication that contains polymorphisms associated with treatment response in hepatitis C patientsPharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agentsEx vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.Natural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patientsmicroRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapiesIFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infectionInvolvement of MAP3K8 and miR-17-5p in poor virologic response to interferon-based combination therapy for chronic hepatitis C.Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C.Expression of selected genes in liver biopsy specimens in relation to early virological response in patients with chronic hepatitis C with HCV mono- and HIV/HCV co-infection.Zinc is a potent and specific inhibitor of IFN-λ3 signalling.Direct-acting antiviral agents and the path to interferon independence.Protective immunity against hepatitis C: many shades of gray.IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infectionReduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis CInterferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissivenessCharacterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C.USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response.An interferon response gene signature is associated with the therapeutic response of hepatitis C patientsAn integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clonesIL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapyHepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.Genetic variations in IL28B and allergic disease in children.Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patientsImmune control and failure in HCV infection--tipping the balance.
P2860
Q22121973-01DF99FA-8024-4BCB-B551-76DB6F34DF74Q24307721-E099CFEB-B30F-48C9-8C60-F0260D10D778Q26801049-7BB97EFA-8C7F-4ECC-B9B5-DB33D4A3CB52Q26824743-C5D0D77E-E38B-4EFD-A6F8-486942F0C088Q26850968-36A60464-079B-43EC-8B78-1F1E5A1054C4Q26866955-1AC22588-25B1-48ED-8C74-A0AD636243BDQ27000742-CDFDD7B7-E7DC-4A4B-A275-6AC47F0CDA37Q27002588-6BBE84EB-EEC1-4E4A-A42C-213903DF6EFCQ27014831-251FBCD1-4C17-4970-9EEC-FBAB8D71ACB0Q27023055-F34AF7FF-9406-42BA-AB3C-20D4B7773759Q28079550-4FB788BA-78A7-41DD-9FC0-8B20E1748D6AQ28255239-A8FF3162-7EB2-4C36-B37E-17C0A90132DDQ28478435-084311BC-C40B-47FD-BB1C-E2A074505161Q28483964-75CDA03A-7912-48C3-B8EA-B60D30DE6444Q28732905-FFA50EAA-7F0C-4792-9A93-B634BEDBF12BQ30365599-CF84E867-3D23-42BD-9EC6-D10B9FA57988Q30444198-9CC058EE-ADA1-4163-B743-84974D7C2C34Q31115968-984BE393-C04E-41EC-A404-954E84E18969Q31141908-D9DABC9A-0E87-42CD-AA6F-86ACB8B1D7E0Q33395929-E7E12DC7-2FA7-44B9-B49F-ADF5698B0D0DQ33569876-F1233AEA-F549-4763-9ABB-599766411606Q33586624-83B3CBEF-F523-4F84-8E36-AECAF288EBA0Q33599325-211D3CB5-DF14-45F5-BB1E-39D1F3AC5D36Q33600034-CD8E77F3-8BD7-4CDB-9C0E-8E88CC74F9C2Q33701131-2FEB22CD-74E5-46ED-B205-0D5F6CC29495Q33720876-AA7DE882-B4B0-4215-B939-11025F24FB8EQ33727347-2703420A-9B84-43AD-915F-C992950A6CAEQ33759224-807A096B-8FD1-45BE-BE7A-CF8586AA655AQ33867243-23901321-1E42-4062-9E3F-9C9704C8361FQ33887760-E0FD6B0F-07F4-4A33-ABE7-36A10C1A2A36Q33922537-2ACB3A60-0299-4558-8AB4-4619F82CF544Q33959382-22722EA1-AFB1-47D3-859C-4E3D97F6E4D8Q33968305-EA97A0F5-E96C-4961-8207-A719B9D24464Q34027569-EC93CA55-EF0B-4F34-B04A-53024DD075A0Q34039791-36ECDD60-5974-42B3-B02E-D021A66ECDA8Q34049322-3D9424D6-0A21-4832-BCF3-35C503A30592Q34103218-6AAE733B-092B-42D7-98BB-1EF03C748EBCQ34147621-AA346B02-4F1E-44C9-AE45-08FC21911681Q34171589-A6D4185E-F91D-4028-912C-3048EACBBD6AQ34178628-C093C8BE-BADF-4D56-B0D9-415C0005DC65
P2860
IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@ast
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@en
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@nl
type
label
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@ast
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@en
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@nl
prefLabel
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@ast
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@en
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@nl
P2093
P2860
P356
P1433
P1476
IL28B genotype is associated w ...... ents with chronic hepatitis C.
@en
P2093
Alexander J Thompson
Alexander McKenzie
David B Goldstein
Detlef Schuppan
John G McHutchison
Kenneth D Cronin
Kevin V Shianna
Keyur Patel
Linda Hong
Shelton S Bradrick
P2860
P304
P356
10.1002/HEP.23912
P407
P577
2010-10-07T00:00:00Z